Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 103,729 $ 113,795
Marketable securities 15,848 0
Restricted cash 1,289 3,620
Accounts receivable, net 38,863 29,563
Inventories 25,969 24,812
Prepaid expenses and other current assets 12,601 13,661
Total current assets 198,299 185,451
Property and equipment, net 36,362 44,400
Goodwill 10,698 9,465
Intangible assets, net 30,763 30,493
Operating lease right-of-use asset 16,501 18,295
Other assets 6,002 8,081
Total assets 298,625 296,185
Current liabilities    
Accounts payable and accrued expenses 33,941 27,153
Accrued payroll 10,629 17,189
Warranty reserve - current 10,116 9,736
Operating lease liability - current 3,163 2,812
Earnout liability 0 13,000
Deferred revenue - current 5,503 6,654
Income tax payable 183 142
Total current liabilities 63,535 76,686
Long-term liabilities    
Warranty reserve - noncurrent 18,194 16,350
Operating lease liability - noncurrent 14,313 16,594
Deferred revenue - noncurrent 3,603 5,747
Deferred tax liability 6,749 6,948
Total liabilities 106,394 122,325
Commitments and contingencies (Note 8)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 shares authorized; 27,232,350 and 23,902,338 shares issued and outstanding as of December 31, 2025 and 2024, respectively 27 24
Additional paid-in capital 363,545 328,174
Accumulated deficit (175,584) (152,837)
Accumulated other comprehensive income (loss) 4,243 (1,501)
Total stockholders' equity 192,231 173,860
Total liabilities and stockholders' equity $ 298,625 $ 296,185